Travere Therapeutics (TVTX) Revenue (2010 - 2026)
Travere Therapeutics (TVTX) revenue from Aug 31, 2010 to Mar 31, 2026. The TTM Travere Therapeutics (TVTX) revenue is $536M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Travere Therapeutics (TVTX) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +96.02% |
| 3 Years TTM | +80.05% |
| 5 Years TTM | +22.05% |
Annual Revenue change of Travere Therapeutics (TVTX)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $127M | -74.08% |
| 2025 | $491M | +110.45% |
| 2024 | $233M | +60.55% |
| 2023 | $145M | +32.69% |
| 2022 | $109M | -16.98% |
| 2021 | $132M | -33.52% |
| 2020 | $198M | +13.11% |
| 2019 | $175M | +6.75% |
| 2018 | $164M | +6.01% |
| 2017 | $155M | +15.98% |
| 2016 | $134M | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | N/A |
| 2011 | $0 | N/A |
| 2010 | $0 | N/A |
Comparison Travere Therapeutics (TVTX) five years revenue CAGR with competitors
Travere Therapeutics (TVTX) five years revenue CAGR is 22.05%.